NCT06715306
Intravenous Versus Oral Treatment of the Main Acute Infections
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 4 months later, enrollment reduced 34%.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Enrollment reduced: 4000 → 2640 participants Show 5 more changesShow less
- Eligibility criteria shortened, about 15 words
- Primary completion pushed from Jan 6, 2027 to Jun 1, 2027
- Study completion pushed from Jan 6, 2028 to Jun 1, 2032
- Study sites: 7 to 8
- Study description revised
- Minor Study sites: 1 to 7v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Jan 6, 2025 to Jan 15, 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Days alive outside hospital (Efficacy)
Timeframe: From randomization date to 30 days
Number of patients requiring treatment with vasopressors
Timeframe: From date of randomization to 30 days
Secondary (11)
Length of hospital stay
Inhospital mortality
30-days mortality
90-days mortality
One-year mortality
Show 6 moreShow less
Five-year mortality
Discharge within 24 hours
Readmission
Intensive care admission
Days on antibiotic treatment within 30 days
Bacteremia
Arms and interventions
Standard CareNo intervention
Standard intravenous treatment in accordance with local or national procedures
Oral treatmentActive comparator
Oral treatment
Other: Oral treatment
Sites
8 sites in 1 country